{"transactions":[{"id":751310,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-03T22:05:29.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":11182,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests on the earlier of June 1, 2027 or the Issuer's 2027 annual meeting of stockholders."}],"balance_after":11182,"derivative":{"exercise_price":5.43,"expiration_date":"2036-06-01","underlying":"Common Stock","underlying_shares":11182},"source":{"system":"sec-edgar","filing":"0001644989-26-000002","document":"form4-06032026_100625.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235912/000164498926000002/form4-06032026_100625.xml","form_type":"4"}},{"id":751309,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-03T22:05:29.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":8720,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Vests on the earlier of June 1, 2027 or the Issuer's 2027 annual meeting of stockholders."}],"balance_after":8720,"source":{"system":"sec-edgar","filing":"0001644989-26-000002","document":"form4-06032026_100625.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235912/000164498926000002/form4-06032026_100625.xml","form_type":"4"}},{"id":1121087,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-05T21:17:21.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":19554,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests on the earlier of June 3, 2026 or the Issuer's 2026 annual meeting of stockholders."}],"balance_after":19554,"derivative":{"exercise_price":6.76,"expiration_date":"2035-06-03","underlying":"Common Stock","underlying_shares":19554},"source":{"system":"sec-edgar","filing":"0001415889-25-015808","document":"form4-06052025_090604.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235912/000141588925015808/form4-06052025_090604.xml","form_type":"4"}},{"id":1393794,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-10-02T19:25:17.000Z","date":"2024-10-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":458,"price":40.63,"value":18608.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2024."}],"balance_after":177533,"source":{"system":"sec-edgar","filing":"0001127602-24-025005","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224025005/form4.xml","form_type":"4"}},{"id":1393793,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-10-02T19:25:17.000Z","date":"2024-10-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":662,"price":40.63,"value":26897.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2023."}],"balance_after":177991,"source":{"system":"sec-edgar","filing":"0001127602-24-025005","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224025005/form4.xml","form_type":"4"}},{"id":1393792,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-10-02T19:25:17.000Z","date":"2024-10-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":616,"price":40.63,"value":25028.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2022."}],"balance_after":178653,"source":{"system":"sec-edgar","filing":"0001127602-24-025005","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224025005/form4.xml","form_type":"4"}},{"id":1393791,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-10-02T19:25:17.000Z","date":"2024-10-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":331,"price":40.63,"value":13448.53,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2021."}],"balance_after":179269,"source":{"system":"sec-edgar","filing":"0001127602-24-025005","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224025005/form4.xml","form_type":"4"}},{"id":1407449,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2024-09-13T16:35:16.000Z","date":"2024-09-12","kind":"exercise","planned":true,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Options vested with respect to 25% of the shares on April 30, 2020 and vested with respect to the remaining shares in 36 equal monthly installments thereafter."}],"balance_after":58477,"derivative":{"exercise_price":0.457,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001127602-24-023899","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224023899/form4.xml","form_type":"4"}},{"id":1407448,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-09-13T16:35:16.000Z","date":"2024-09-12","kind":"sale","planned":true,"acquired":false,"shares":500,"price":46.34,"value":23170.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $46.24 to $46.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":179600,"source":{"system":"sec-edgar","filing":"0001127602-24-023899","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224023899/form4.xml","form_type":"4"}},{"id":1407447,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-09-13T16:35:16.000Z","date":"2024-09-12","kind":"sale","planned":true,"acquired":false,"shares":891,"price":45.8,"value":40807.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from  $45.24 to $46.23. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":180100,"source":{"system":"sec-edgar","filing":"0001127602-24-023899","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224023899/form4.xml","form_type":"4"}},{"id":1407446,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-09-13T16:35:16.000Z","date":"2024-09-12","kind":"sale","planned":true,"acquired":false,"shares":1609,"price":44.38,"value":71407.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from  $44.13 to $44.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":180991,"source":{"system":"sec-edgar","filing":"0001127602-24-023899","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224023899/form4.xml","form_type":"4"}},{"id":1407445,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-09-13T16:35:16.000Z","date":"2024-09-12","kind":"exercise","planned":true,"acquired":true,"shares":3000,"price":0.457,"value":1371.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2023."}],"balance_after":182600,"source":{"system":"sec-edgar","filing":"0001127602-24-023899","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224023899/form4.xml","form_type":"4"}},{"id":1413672,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-09-05T20:43:41.000Z","date":"2024-09-03","kind":"grant","planned":false,"acquired":true,"shares":36136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests as to one-third of the shares on each annual anniversary of the date of grant."}],"balance_after":36136,"derivative":{"exercise_price":9.05,"expiration_date":"2034-09-02","underlying":"Common Stock","underlying_shares":36136},"source":{"system":"sec-edgar","filing":"0001415889-24-022937","document":"form4-09052024_080937.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235912/000141588924022937/form4-09052024_080937.xml","form_type":"4"}},{"id":1433395,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2024-08-14T17:10:16.000Z","date":"2024-08-12","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Options vested with respect to 25% of the shares on April 30, 2020 and vested with respect to the remaining shares in 36 equal monthly installments thereafter."}],"balance_after":61477,"derivative":{"exercise_price":0.457,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001127602-24-022199","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224022199/form4.xml","form_type":"4"}},{"id":1433394,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-08-14T17:10:16.000Z","date":"2024-08-12","kind":"sale","planned":true,"acquired":false,"shares":426,"price":48.56,"value":20686.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $48.50 to $48.64. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 373 shares acquired on July 31, 2024 through the Issuer's Employee Stock Purchase Program."}],"balance_after":179600,"source":{"system":"sec-edgar","filing":"0001127602-24-022199","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224022199/form4.xml","form_type":"4"}},{"id":1433393,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-08-14T17:10:16.000Z","date":"2024-08-12","kind":"sale","planned":true,"acquired":false,"shares":4574,"price":47.94,"value":219277.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $47.46 to $48.33. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":180026,"source":{"system":"sec-edgar","filing":"0001127602-24-022199","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224022199/form4.xml","form_type":"4"}},{"id":1433392,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-08-14T17:10:16.000Z","date":"2024-08-12","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":0.457,"value":2285.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2023."}],"balance_after":184600,"source":{"system":"sec-edgar","filing":"0001127602-24-022199","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224022199/form4.xml","form_type":"4"}},{"id":1453539,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2024-07-16T16:40:46.000Z","date":"2024-07-12","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Options vested with respect to 25% of the shares on April 30, 2020 and vested with respect to the remaining shares in 36 equal monthly installments thereafter."}],"balance_after":66477,"derivative":{"exercise_price":0.457,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001127602-24-020517","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224020517/form4.xml","form_type":"4"}},{"id":1453538,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-07-16T16:40:46.000Z","date":"2024-07-12","kind":"sale","planned":true,"acquired":false,"shares":1965,"price":54.31,"value":106719.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $54.16 to $54.52. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":179227,"source":{"system":"sec-edgar","filing":"0001127602-24-020517","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224020517/form4.xml","form_type":"4"}},{"id":1453537,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-07-16T16:40:46.000Z","date":"2024-07-12","kind":"sale","planned":true,"acquired":false,"shares":3035,"price":53.72,"value":163040.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $53.16 to $54.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":181192,"source":{"system":"sec-edgar","filing":"0001127602-24-020517","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224020517/form4.xml","form_type":"4"}},{"id":1453536,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-07-16T16:40:46.000Z","date":"2024-07-12","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":0.457,"value":2285.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2023."}],"balance_after":184227,"source":{"system":"sec-edgar","filing":"0001127602-24-020517","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224020517/form4.xml","form_type":"4"}},{"id":1459420,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-07-03T15:01:44.000Z","date":"2024-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":458,"price":50.19,"value":22987.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2024."}],"balance_after":179227,"source":{"system":"sec-edgar","filing":"0001127602-24-020036","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224020036/form4.xml","form_type":"4"}},{"id":1459419,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-07-03T15:01:44.000Z","date":"2024-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":662,"price":50.19,"value":33225.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2023."}],"balance_after":179685,"source":{"system":"sec-edgar","filing":"0001127602-24-020036","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224020036/form4.xml","form_type":"4"}},{"id":1459418,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-07-03T15:01:44.000Z","date":"2024-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":616,"price":50.19,"value":30917.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2022."}],"balance_after":180347,"source":{"system":"sec-edgar","filing":"0001127602-24-020036","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224020036/form4.xml","form_type":"4"}},{"id":1459417,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-07-03T15:01:44.000Z","date":"2024-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":331,"price":50.19,"value":16612.89,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2021."}],"balance_after":180963,"source":{"system":"sec-edgar","filing":"0001127602-24-020036","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224020036/form4.xml","form_type":"4"}},{"id":1478585,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2024-06-14T16:52:03.000Z","date":"2024-06-12","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Options vested with respect to 25% of the shares on April 30, 2020 and vested with respect to the remaining shares in 36 equal monthly installments thereafter."}],"balance_after":71477,"derivative":{"exercise_price":0.457,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001127602-24-018741","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224018741/form4.xml","form_type":"4"}},{"id":1478584,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-06-14T16:52:03.000Z","date":"2024-06-12","kind":"sale","planned":true,"acquired":false,"shares":2502,"price":48.04,"value":120196.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $47.79 to $48.36. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":181294,"source":{"system":"sec-edgar","filing":"0001127602-24-018741","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224018741/form4.xml","form_type":"4"}},{"id":1478583,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-06-14T16:52:03.000Z","date":"2024-06-12","kind":"sale","planned":true,"acquired":false,"shares":2498,"price":47.15,"value":117780.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $46.75 to $47.66. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":183796,"source":{"system":"sec-edgar","filing":"0001127602-24-018741","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224018741/form4.xml","form_type":"4"}},{"id":1478582,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-06-14T16:52:03.000Z","date":"2024-06-12","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":0.457,"value":2285.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2023."}],"balance_after":186294,"source":{"system":"sec-edgar","filing":"0001127602-24-018741","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224018741/form4.xml","form_type":"4"}},{"id":1515652,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2024-05-15T16:39:21.000Z","date":"2024-05-13","kind":"exercise","planned":true,"acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Options vested with respect to 25% of the shares on April 30, 2020 and vested with respect to the remaining shares in 36 equal monthly installments thereafter."}],"balance_after":76477,"derivative":{"exercise_price":0.457,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001127602-24-015472","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224015472/form4.xml","form_type":"4"}},{"id":1515651,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-15T16:39:21.000Z","date":"2024-05-13","kind":"sale","planned":true,"acquired":false,"shares":2200,"price":46.55,"value":102410.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $46.39 to $46.93. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":181294,"source":{"system":"sec-edgar","filing":"0001127602-24-015472","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224015472/form4.xml","form_type":"4"}},{"id":1515650,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-15T16:39:21.000Z","date":"2024-05-13","kind":"sale","planned":true,"acquired":false,"shares":3500,"price":45.73,"value":160055.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $45.37 to $46.23. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":183494,"source":{"system":"sec-edgar","filing":"0001127602-24-015472","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224015472/form4.xml","form_type":"4"}},{"id":1515649,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-15T16:39:21.000Z","date":"2024-05-13","kind":"sale","planned":true,"acquired":false,"shares":300,"price":44.49,"value":13347.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $44.02 to $44.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":186994,"source":{"system":"sec-edgar","filing":"0001127602-24-015472","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224015472/form4.xml","form_type":"4"}},{"id":1515648,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-15T16:39:21.000Z","date":"2024-05-13","kind":"exercise","planned":true,"acquired":true,"shares":6000,"price":0.457,"value":2742.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2023."}],"balance_after":187294,"source":{"system":"sec-edgar","filing":"0001127602-24-015472","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224015472/form4.xml","form_type":"4"}},{"id":1540983,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2024-04-16T16:32:18.000Z","date":"2024-04-12","kind":"exercise","planned":true,"acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options vested with respect to 25% of the shares on April 30, 2020 and vested with respect to the remaining shares in 36 equal monthly installments thereafter."}],"balance_after":82477,"derivative":{"exercise_price":0.457,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001127602-24-012998","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224012998/form4.xml","form_type":"4"}},{"id":1540982,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-04-16T16:32:18.000Z","date":"2024-04-12","kind":"sale","planned":true,"acquired":false,"shares":6000,"price":40.96,"value":245760.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $40.54 to $41.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":181294,"source":{"system":"sec-edgar","filing":"0001127602-24-012998","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224012998/form4.xml","form_type":"4"}},{"id":1540981,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-04-16T16:32:18.000Z","date":"2024-04-12","kind":"exercise","planned":true,"acquired":true,"shares":6000,"price":0.457,"value":2742.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2023."}],"balance_after":187294,"source":{"system":"sec-edgar","filing":"0001127602-24-012998","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224012998/form4.xml","form_type":"4"}},{"id":1548758,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-04-03T16:40:34.000Z","date":"2024-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":458,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2024."}],"balance_after":181294,"source":{"system":"sec-edgar","filing":"0001127602-24-012243","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224012243/form4.xml","form_type":"4"}},{"id":1548757,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-04-03T16:40:34.000Z","date":"2024-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":662,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2023."}],"balance_after":181752,"source":{"system":"sec-edgar","filing":"0001127602-24-012243","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224012243/form4.xml","form_type":"4"}},{"id":1548756,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-04-03T16:40:34.000Z","date":"2024-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":616,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2022."}],"balance_after":182414,"source":{"system":"sec-edgar","filing":"0001127602-24-012243","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224012243/form4.xml","form_type":"4"}},{"id":1548755,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-04-03T16:40:34.000Z","date":"2024-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":331,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2021."}],"balance_after":183030,"source":{"system":"sec-edgar","filing":"0001127602-24-012243","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224012243/form4.xml","form_type":"4"}},{"id":1576297,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2024-03-14T16:31:29.000Z","date":"2024-03-12","kind":"exercise","planned":true,"acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options vested with respect to 25% of the shares on April 30, 2020 and vested with respect to the remaining shares in 36 equal monthly installments thereafter."}],"balance_after":88477,"derivative":{"exercise_price":0.457,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001127602-24-010133","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224010133/form4.xml","form_type":"4"}},{"id":1576296,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-14T16:31:29.000Z","date":"2024-03-12","kind":"sale","planned":true,"acquired":false,"shares":1,"price":42.58,"value":42.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2023."}],"balance_after":183361,"source":{"system":"sec-edgar","filing":"0001127602-24-010133","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224010133/form4.xml","form_type":"4"}},{"id":1576295,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-14T16:31:29.000Z","date":"2024-03-12","kind":"sale","planned":true,"acquired":false,"shares":5999,"price":41.91,"value":251418.09,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $41.41 to $42.32. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":183362,"source":{"system":"sec-edgar","filing":"0001127602-24-010133","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224010133/form4.xml","form_type":"4"}},{"id":1576294,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-14T16:31:29.000Z","date":"2024-03-12","kind":"exercise","planned":true,"acquired":true,"shares":6000,"price":0.457,"value":2742.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2023."}],"balance_after":189361,"source":{"system":"sec-edgar","filing":"0001127602-24-010133","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224010133/form4.xml","form_type":"4"}},{"id":1628182,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2024-02-21T21:55:13.000Z","date":"2024-02-16","kind":"grant","planned":false,"acquired":true,"shares":16231,"price":58.44,"value":948539.64,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents options to purchase shares of Issuer common stock which were granted on February 16, 2024 under the Issuer's 2020 Incentive Award Plan and are scheduled to become vested and exercisable on a quarterly basis, with the first tranche vesting on April 1, 2024."}],"balance_after":16231,"derivative":{"exercise_price":58.44,"expiration_date":"2031-02-15","underlying":"Common Stock","underlying_shares":16231},"source":{"system":"sec-edgar","filing":"0001127602-24-006230","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224006230/form4.xml","form_type":"4"}},{"id":1628181,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-21T21:55:13.000Z","date":"2024-02-16","kind":"grant","planned":false,"acquired":true,"shares":14812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents annual restricted stock units (\"RSUs\") awarded to the reporting person, with a vesting commencement date of January 1, 2024 (the \"Vesting Commencement Date\"). 1/16th of the RSUs shall vest on each quarterly anniversary of the Vesting Commencement Date, subject to continued service through the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 61 shares acquired on January 31, 2024 under the Employee Stock Purchase Plan."}],"balance_after":183361,"source":{"system":"sec-edgar","filing":"0001127602-24-006230","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224006230/form4.xml","form_type":"4"}},{"id":1691160,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-01-03T12:24:18.000Z","date":"2024-01-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":733,"price":64.92,"value":47586.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2023."}],"balance_after":168488,"source":{"system":"sec-edgar","filing":"0001127602-24-000278","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224000278/form4.xml","form_type":"4"}},{"id":1691159,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-01-03T12:24:18.000Z","date":"2024-01-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":682,"price":64.92,"value":44275.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2022."}],"balance_after":169221,"source":{"system":"sec-edgar","filing":"0001127602-24-000278","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224000278/form4.xml","form_type":"4"}},{"id":1691158,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-01-03T12:24:18.000Z","date":"2024-01-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":327,"price":64.92,"value":21228.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2021."}],"balance_after":169903,"source":{"system":"sec-edgar","filing":"0001127602-24-000278","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224000278/form4.xml","form_type":"4"}},{"id":1710672,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-12-14T16:35:52.000Z","date":"2023-12-12","kind":"exercise","planned":true,"acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Options vested with respect to 25% of the shares on April 30, 2020 and vested with respect to the remaining shares in 36 equal monthly installments thereafter."}],"balance_after":94477,"derivative":{"exercise_price":0.457,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001127602-23-029622","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223029622/form4.xml","form_type":"4"}},{"id":1710671,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-14T16:35:52.000Z","date":"2023-12-12","kind":"sale","planned":true,"acquired":false,"shares":3582,"price":63.16,"value":226239.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $62.75 to $63.66. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":170230,"source":{"system":"sec-edgar","filing":"0001127602-23-029622","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223029622/form4.xml","form_type":"4"}},{"id":1710670,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-14T16:35:52.000Z","date":"2023-12-12","kind":"sale","planned":true,"acquired":false,"shares":2918,"price":62.24,"value":181616.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $61.73 to $62.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":173812,"source":{"system":"sec-edgar","filing":"0001127602-23-029622","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223029622/form4.xml","form_type":"4"}},{"id":1710669,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-14T16:35:52.000Z","date":"2023-12-12","kind":"exercise","planned":true,"acquired":true,"shares":6500,"price":0.457,"value":2970.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."}],"balance_after":176730,"source":{"system":"sec-edgar","filing":"0001127602-23-029622","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223029622/form4.xml","form_type":"4"}},{"id":1740439,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-11-15T16:32:36.000Z","date":"2023-11-13","kind":"exercise","planned":true,"acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Options vested with respect to 25% of the shares on April 30, 2020 and vested with respect to the remaining shares in 36 equal monthly installments thereafter."}],"balance_after":100977,"derivative":{"exercise_price":0.457,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001127602-23-027436","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223027436/form4.xml","form_type":"4"}},{"id":1740438,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-11-15T16:32:36.000Z","date":"2023-11-13","kind":"sale","planned":true,"acquired":false,"shares":400,"price":56.93,"value":22772.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $56.82 to $57.81. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":170230,"source":{"system":"sec-edgar","filing":"0001127602-23-027436","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223027436/form4.xml","form_type":"4"}},{"id":1740437,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-11-15T16:32:36.000Z","date":"2023-11-13","kind":"sale","planned":true,"acquired":false,"shares":4500,"price":56.18,"value":252810.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $55.82 to $56.81. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":170630,"source":{"system":"sec-edgar","filing":"0001127602-23-027436","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223027436/form4.xml","form_type":"4"}},{"id":1740436,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-11-15T16:32:36.000Z","date":"2023-11-13","kind":"sale","planned":true,"acquired":false,"shares":1600,"price":55.49,"value":88784.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from  $54.82 to $55.81. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":175130,"source":{"system":"sec-edgar","filing":"0001127602-23-027436","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223027436/form4.xml","form_type":"4"}},{"id":1740435,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-11-15T16:32:36.000Z","date":"2023-11-13","kind":"exercise","planned":true,"acquired":true,"shares":6500,"price":0.457,"value":2970.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."}],"balance_after":176730,"source":{"system":"sec-edgar","filing":"0001127602-23-027436","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223027436/form4.xml","form_type":"4"}},{"id":1759691,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-10-16T16:32:58.000Z","date":"2023-10-12","kind":"exercise","planned":true,"acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Options vested with respect to 25% of the shares on April 30, 2020 and vested with respect to the remaining shares in 36 equal monthly installments thereafter."}],"balance_after":107477,"derivative":{"exercise_price":0.457,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001127602-23-025901","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223025901/form4.xml","form_type":"4"}},{"id":1759690,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-10-16T16:32:58.000Z","date":"2023-10-12","kind":"sale","planned":true,"acquired":false,"shares":500,"price":57.78,"value":28890.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $57.69 to $57.96. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":170230,"source":{"system":"sec-edgar","filing":"0001127602-23-025901","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223025901/form4.xml","form_type":"4"}},{"id":1759689,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-10-16T16:32:58.000Z","date":"2023-10-12","kind":"sale","planned":true,"acquired":false,"shares":900,"price":56.86,"value":51174.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $56.55 to $57.52. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":170730,"source":{"system":"sec-edgar","filing":"0001127602-23-025901","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223025901/form4.xml","form_type":"4"}},{"id":1759688,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-10-16T16:32:58.000Z","date":"2023-10-12","kind":"sale","planned":true,"acquired":false,"shares":2490,"price":55.64,"value":138543.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $55.41 to $56.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":171630,"source":{"system":"sec-edgar","filing":"0001127602-23-025901","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223025901/form4.xml","form_type":"4"}},{"id":1759687,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-10-16T16:32:58.000Z","date":"2023-10-12","kind":"sale","planned":true,"acquired":false,"shares":2610,"price":55.07,"value":143732.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $54.39 to $55.36. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":174120,"source":{"system":"sec-edgar","filing":"0001127602-23-025901","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223025901/form4.xml","form_type":"4"}},{"id":1759686,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-10-16T16:32:58.000Z","date":"2023-10-12","kind":"exercise","planned":true,"acquired":true,"shares":6500,"price":0.457,"value":2970.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."}],"balance_after":176730,"source":{"system":"sec-edgar","filing":"0001127602-23-025901","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223025901/form4.xml","form_type":"4"}},{"id":1766669,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-10-03T21:22:46.000Z","date":"2023-10-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":647,"price":65.4,"value":42313.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2023."}],"balance_after":170230,"source":{"system":"sec-edgar","filing":"0001127602-23-025398","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223025398/form4.xml","form_type":"4"}},{"id":1766668,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-10-03T21:22:46.000Z","date":"2023-10-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":602,"price":65.4,"value":39370.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2022."}],"balance_after":170877,"source":{"system":"sec-edgar","filing":"0001127602-23-025398","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223025398/form4.xml","form_type":"4"}},{"id":1766667,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-10-03T21:22:46.000Z","date":"2023-10-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":323,"price":65.4,"value":21124.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2021."}],"balance_after":171479,"source":{"system":"sec-edgar","filing":"0001127602-23-025398","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223025398/form4.xml","form_type":"4"}},{"id":1780831,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-09-14T16:41:48.000Z","date":"2023-09-12","kind":"exercise","planned":true,"acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Options vested with respect to 25% of the shares on April 30, 2020 and vest with respect to the remaining shares in 36 equal monthly installments thereafter."}],"balance_after":113977,"derivative":{"exercise_price":0.457,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001127602-23-024195","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223024195/form4.xml","form_type":"4"}},{"id":1780830,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-14T16:41:48.000Z","date":"2023-09-12","kind":"sale","planned":true,"acquired":false,"shares":3325,"price":68.35,"value":227263.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $68.15 to $68.91. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":171802,"source":{"system":"sec-edgar","filing":"0001127602-23-024195","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223024195/form4.xml","form_type":"4"}},{"id":1780829,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-14T16:41:48.000Z","date":"2023-09-12","kind":"sale","planned":true,"acquired":false,"shares":2120,"price":67.7,"value":143524.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $67.15 to $68.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":175127,"source":{"system":"sec-edgar","filing":"0001127602-23-024195","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223024195/form4.xml","form_type":"4"}},{"id":1780828,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-14T16:41:48.000Z","date":"2023-09-12","kind":"sale","planned":true,"acquired":false,"shares":1055,"price":66.59,"value":70252.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $66.11 to $66.89. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":177247,"source":{"system":"sec-edgar","filing":"0001127602-23-024195","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223024195/form4.xml","form_type":"4"}},{"id":1780827,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-14T16:41:48.000Z","date":"2023-09-12","kind":"exercise","planned":true,"acquired":true,"shares":6500,"price":0.457,"value":2970.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."}],"balance_after":178302,"source":{"system":"sec-edgar","filing":"0001127602-23-024195","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223024195/form4.xml","form_type":"4"}},{"id":1805253,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-08-16T16:46:39.000Z","date":"2023-08-14","kind":"exercise","planned":true,"acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Options vested with respect to 25% of the shares on April 30, 2020 and vest with respect to the remaining shares in 36 equal monthly installments thereafter."}],"balance_after":120477,"derivative":{"exercise_price":0.457,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001127602-23-022729","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223022729/form4.xml","form_type":"4"}},{"id":1805252,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-08-16T16:46:39.000Z","date":"2023-08-14","kind":"sale","planned":true,"acquired":false,"shares":1367,"price":71.71,"value":98027.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $71.67 to $71.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"The balance includes 320 shares acquired on July 31, 2023, under the Company's Employee Stock Purchase Plan."}],"balance_after":171802,"source":{"system":"sec-edgar","filing":"0001127602-23-022729","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223022729/form4.xml","form_type":"4"}},{"id":1805251,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-08-16T16:46:39.000Z","date":"2023-08-14","kind":"sale","planned":true,"acquired":false,"shares":2397,"price":71.66,"value":171769.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $70.66 to $71.57. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":173169,"source":{"system":"sec-edgar","filing":"0001127602-23-022729","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223022729/form4.xml","form_type":"4"}},{"id":1805250,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-08-16T16:46:39.000Z","date":"2023-08-14","kind":"sale","planned":true,"acquired":false,"shares":640,"price":70.17,"value":44908.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $69.65 to $70.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":175566,"source":{"system":"sec-edgar","filing":"0001127602-23-022729","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223022729/form4.xml","form_type":"4"}},{"id":1805249,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-08-16T16:46:39.000Z","date":"2023-08-14","kind":"sale","planned":true,"acquired":false,"shares":1187,"price":68.92,"value":81808.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from  $68.57 to $69.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":176206,"source":{"system":"sec-edgar","filing":"0001127602-23-022729","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223022729/form4.xml","form_type":"4"}},{"id":1805248,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-08-16T16:46:39.000Z","date":"2023-08-14","kind":"sale","planned":true,"acquired":false,"shares":909,"price":67.7,"value":61539.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from  $67.42 to $68.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":177393,"source":{"system":"sec-edgar","filing":"0001127602-23-022729","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223022729/form4.xml","form_type":"4"}},{"id":1805247,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-08-16T16:46:39.000Z","date":"2023-08-14","kind":"exercise","planned":true,"acquired":true,"shares":6500,"price":0.457,"value":2970.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."}],"balance_after":178302,"source":{"system":"sec-edgar","filing":"0001127602-23-022729","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223022729/form4.xml","form_type":"4"}},{"id":1829456,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-07-14T16:35:20.000Z","date":"2023-07-12","kind":"exercise","planned":true,"acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Options vested with respected with 25% of the underlying shares on April 30, 2020 and vest with respect to the remaining shares in 36 equal monthly installment thereafter."}],"balance_after":126977,"derivative":{"exercise_price":0.457,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001127602-23-020727","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223020727/form4.xml","form_type":"4"}},{"id":1829455,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-07-14T16:35:20.000Z","date":"2023-07-12","kind":"sale","planned":true,"acquired":false,"shares":800,"price":57.07,"value":45656.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $56.77 to $57.45. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":171482,"source":{"system":"sec-edgar","filing":"0001127602-23-020727","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223020727/form4.xml","form_type":"4"}},{"id":1829454,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-07-14T16:35:20.000Z","date":"2023-07-12","kind":"sale","planned":true,"acquired":false,"shares":5700,"price":56.12,"value":319884.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $55.71 to $56.52. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":172282,"source":{"system":"sec-edgar","filing":"0001127602-23-020727","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223020727/form4.xml","form_type":"4"}},{"id":1829453,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-07-14T16:35:20.000Z","date":"2023-07-12","kind":"exercise","planned":true,"acquired":true,"shares":6500,"price":0.457,"value":2970.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."}],"balance_after":177982,"source":{"system":"sec-edgar","filing":"0001127602-23-020727","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223020727/form4.xml","form_type":"4"}},{"id":1835302,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-07-05T18:14:19.000Z","date":"2023-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":647,"price":58.14,"value":37616.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2023."}],"balance_after":171482,"source":{"system":"sec-edgar","filing":"0001127602-23-020262","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223020262/form4.xml","form_type":"4"}},{"id":1835301,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-07-05T18:14:19.000Z","date":"2023-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":602,"price":58.14,"value":35000.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2022."}],"balance_after":172129,"source":{"system":"sec-edgar","filing":"0001127602-23-020262","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223020262/form4.xml","form_type":"4"}},{"id":1835300,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-07-05T18:14:19.000Z","date":"2023-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":323,"price":58.14,"value":18779.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2021."}],"balance_after":172731,"source":{"system":"sec-edgar","filing":"0001127602-23-020262","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223020262/form4.xml","form_type":"4"}},{"id":1856915,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-06-13T17:48:02.000Z","date":"2023-06-12","kind":"exercise","planned":true,"acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Options vested with respect to 25% of the shares on April 30, 2020 and vest with respect to the remaining shares in 36 equal monthly installment thereafter."}],"balance_after":133477,"derivative":{"exercise_price":0.457,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001127602-23-018670","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223018670/form4.xml","form_type":"4"}},{"id":1856914,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-13T17:48:02.000Z","date":"2023-06-12","kind":"sale","planned":true,"acquired":false,"shares":800,"price":60.13,"value":48104.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $59.78 to $60.42. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":173054,"source":{"system":"sec-edgar","filing":"0001127602-23-018670","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223018670/form4.xml","form_type":"4"}},{"id":1856913,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-13T17:48:02.000Z","date":"2023-06-12","kind":"sale","planned":true,"acquired":false,"shares":5700,"price":59.12,"value":336984.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from  $58.60 to $59.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":173854,"source":{"system":"sec-edgar","filing":"0001127602-23-018670","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223018670/form4.xml","form_type":"4"}},{"id":1856912,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-13T17:48:02.000Z","date":"2023-06-12","kind":"exercise","planned":true,"acquired":true,"shares":6500,"price":0.457,"value":2970.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."}],"balance_after":179554,"source":{"system":"sec-edgar","filing":"0001127602-23-018670","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223018670/form4.xml","form_type":"4"}},{"id":1891048,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-05-16T17:41:02.000Z","date":"2023-05-12","kind":"exercise","planned":true,"acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Options vested with respect to 25% of the shares on April 30, 2020 and vest with respect to the remaining shares in 36 equal monthly installment thereafter."}],"balance_after":139977,"derivative":{"exercise_price":0.457,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001127602-23-015792","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223015792/form4.xml","form_type":"4"}},{"id":1891047,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-16T17:41:02.000Z","date":"2023-05-12","kind":"sale","planned":true,"acquired":false,"shares":2521,"price":70.69,"value":178209.49,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from  $70.44 to $71.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":173054,"source":{"system":"sec-edgar","filing":"0001127602-23-015792","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223015792/form4.xml","form_type":"4"}},{"id":1891046,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-16T17:41:02.000Z","date":"2023-05-12","kind":"sale","planned":true,"acquired":false,"shares":3729,"price":69.96,"value":260880.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $69.37 to $70.32. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":175575,"source":{"system":"sec-edgar","filing":"0001127602-23-015792","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223015792/form4.xml","form_type":"4"}},{"id":1891045,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-16T17:41:02.000Z","date":"2023-05-12","kind":"sale","planned":true,"acquired":false,"shares":3100,"price":70.63,"value":218953.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $70.31 to $71.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":179304,"source":{"system":"sec-edgar","filing":"0001127602-23-015792","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223015792/form4.xml","form_type":"4"}},{"id":1891044,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-16T17:41:02.000Z","date":"2023-05-12","kind":"sale","planned":true,"acquired":false,"shares":3400,"price":69.93,"value":237762.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from  $69.29 to $70.25. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":182404,"source":{"system":"sec-edgar","filing":"0001127602-23-015792","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223015792/form4.xml","form_type":"4"}},{"id":1891043,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-16T17:41:02.000Z","date":"2023-05-12","kind":"exercise","planned":true,"acquired":true,"shares":6500,"price":0.457,"value":2970.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."}],"balance_after":185804,"source":{"system":"sec-edgar","filing":"0001127602-23-015792","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223015792/form4.xml","form_type":"4"}},{"id":1919412,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-04-14T16:44:06.000Z","date":"2023-04-12","kind":"exercise","planned":true,"acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Options vested with respect to 25% of the shares on April 30, 2020 and vest with respect to the remaining shares in 36 equal monthly installment thereafter."}],"balance_after":146477,"derivative":{"exercise_price":0.457,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001127602-23-012934","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223012934/form4.xml","form_type":"4"}},{"id":1919411,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-04-14T16:44:06.000Z","date":"2023-04-12","kind":"sale","planned":true,"acquired":false,"shares":1015,"price":66.15,"value":67142.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This transaction was executed in multiple trades at prices ranging from $66.04 to $66.26. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":179304,"source":{"system":"sec-edgar","filing":"0001127602-23-012934","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223012934/form4.xml","form_type":"4"}},{"id":1919410,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":41680,"kind":"person","name":"Hill, Mitch C.","position":1,"cik":"0001644989","reported_name":"Hill, Mitch C.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-04-14T16:44:06.000Z","date":"2023-04-12","kind":"sale","planned":true,"acquired":false,"shares":658,"price":65.45,"value":43066.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $65.00 to $65.94. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":180319,"source":{"system":"sec-edgar","filing":"0001127602-23-012934","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223012934/form4.xml","form_type":"4"}}],"next_cursor":"2023-04-14T16:44:06.000000Z,1919410"}